Zdrowie i gospodarka · 16/12/2025
FDA Announces Final Guidance on Sponsor Responsibilities for IND Safety Reporting
The FDA has released a final guidance for industry on sponsor responsibilities for safety reporting in investigational new drug applications and bioavailability/bioequivalence studies, finalizing a draft issued in June 2021.
Source: Federal Register — Food and Drug AdministrationOpen original release →